Introduction {#s1}
============

A central mystery in auditory neuroscience is the identity of the molecules making up the pore of the hair cell's transduction channel, a cation-selective channel that responds to mechanical stimuli and produces a receptor potential in the cell. Transduction channels are gated by tension in tip links, thin extracellular filaments made from the cadherins CDH23 and PCDH15 (Siemens et al., [@B54]; Sollner et al., [@B55]; Alagramam et al., [@B2]). PCDH15 is located at the base of the tip link (Kazmierczak et al., [@B31]), where the transduction channel is located (Beurg et al., [@B7]). Theoretical modeling suggests that the tip link binds to the transduction channel complex (Powers et al., [@B46]), so PCDH15 might interact directly with the transduction channel. The ion channel HCN1 has been reported to bind to PCDH15 (Ramakrishnan et al., [@B48], [@B47]), but *Hcn1* knockouts have normal hearing (Horwitz et al., [@B28]). By contrast, strong evidence suggests that the channel complex contains the transmembrane proteins TMC1 and TMC2 (Kawashima et al., [@B30]; Pan et al., [@B43]), TMIE (Zhao et al., [@B71]) and LHFPL5 (Xiong et al., [@B68]); moreover, PCDH15 interacts with both TMC1 and TMC2 (Maeda et al., [@B36]; Beurg et al., [@B8]). Nevertheless, while the TMCs do influence transduction-channel conductance and permeability properties (Pan et al., [@B43]; Beurg et al., [@B6]), evidence that any of these proteins contributes directly to the ion-permeation pathway is lacking.

Because they carry out a wide variety of cellular functions, including sensory transduction, the 33-member transient receptor potential (TRP) family might well contain the transduction-channel pore molecule (Venkatachalam and Montell, [@B57]; Zanini and Göpfert, [@B69]). Many TRP channels are present in the inner ear; a comprehensive quantitative RT-PCR investigation of TRP channel expression during cochlear development detected transcripts for 30 different TRP genes (Asai et al., [@B3]). Several TRP channels have been advanced specifically as candidates for the transduction channel, but all evidence so far has ruled out these candidates (Fettiplace and Kim, [@B18]).

Our preliminary evidence raised the possibility that TRPV6, TRPM6, or TRPM7 might be part of the transduction channel. Interestingly, TRPV channels play key roles in transduction in fly mechanoreceptors (Gong et al., [@B22]; Kernan, [@B32]; Lehnert et al., [@B35]; Zhang et al., [@B70]). As it is highly selective for Ca^2+^ (Owsianik et al., [@B42]), TRPV6 is less likely as a candidate for the transduction channel than other channels; nevertheless, the transduction channel's permeability and conductance can change substantially depending on other components expressed (Xiong et al., [@B68]; Beurg et al., [@B8]). TRPM7, a member of the melanostatin subfamily, has been implicated in mechanosensation (Bessac and Fleig, [@B5]; Numata et al., [@B40],[@B41]; Wei et al., [@B63]; Xiao et al., [@B67]). TRPM7 and its closely related paralog TRPM6 uniquely possess a C-terminal kinase domain; these channels are thought to regulate Mg^2+^ homeostasis as well as cell death, proliferation, differentiation, and migration (Chubanov and Gudermann, [@B11]; Fleig and Chubanov, [@B19]). *Trpv6*, *Trpm6* and *Trpm7* transcripts were all detected in cochlea (Asai et al., [@B3]); *Trpm6* levels increased during development, while *Trpv6* and *Trpm7* decreased. The *Trpv6* paralog *Trpv5* was seen in only a fraction of the samples and may not be significantly expressed in the cochlea. Both *Trpm6* and *Trpm7* were detected in a cochlear cDNA library using conventional PCR, but *Trpv5* and *Trpv6* were not (Cuajungco et al., [@B12]).

Because a cysteine-substitution mutation in TRPV6 (M527C) renders this channel sensitive to methanethiosulfonate (MTS) reagents applied from the extracellular solution (Voets et al., [@B58]), we generated M527C-*Trpv6* knock-in mice. Mechanotransduction was insensitive to MTS reagents, however, in both heterozygote and homozygote hair cells from this line. Similarly, mechanotransduction in hair cells was not affected by conditions that should alter TRPM6 or TRPM7 function, and conditional deletion of the *Trpm6* and *Trpm7* genes in hair cells did not affect auditory function. We suggest that TRPV6, TRPM6, and TRPM7 should be added to the long list of ion channels that have been shown to not be part of the transduction channel (Horwitz et al., [@B28]).

Materials and Methods {#s2}
=====================

Animal Research {#s2-1}
---------------

This study was carried out in compliance with the Animal Welfare Act regulations and the Office of Laboratory Animal Welfare---Public Health Service Policy on Humane Care and Use of Laboratory Animals. Protocols were approved by the Institutional Animal Care and Use Committees (IACUC) of Oregon Health & Science University, Stanford University, and Scripps Research Institute.

Generation of Mouse Lines {#s2-2}
-------------------------

For *M527-Trpv6*, we generated a targeted construct that contained (5′ to 3′) a short homology arm (1.8 kb) with an added loxP-flanked neomycin resistance cassette, exon 13 including the codon encoding M527 to a cysteine and an introduced *ScaI* site for screening, a long homology arm (5.3 kb), and a diphtheria toxin cassette. The targeting construct was linearized with *XhoI* for electroporation into ES cells. Screening was carried out on the 5′ and 3′ arms using PCR, with TOPO-cloning of PCR products to verify that the correct genomic DNA region was targeted. Mice were generated from the correctly-targeted ES cells by the University of Cincinnati Gene-Targeted Mouse Service. After blastocyst injections, founders were identified by coat color chimerism and were bred to C57BL/6 mice for \>6 generations. Mice were genotyped using PCR, with AAATGGGAACCAGATTCATCTCA as the forward primer and ACTATACAAAAGGGTAACCTACCCACA as the reverse primer. The amplified samples were digested with *BamHI* (the knock-in removes a *BamHI* site) and analyzed by electrophoresis.

We obtained *Trpm6^tm1a(KOMP)Wtsi^* ES cells from the UC Davis KOMP repository (clones EPD0741_2\_G10 and EPD0741_2\_G11). After blastocyst injections, founders were identified by coat color chimerism and targeting was verified by PCR analysis. Founders were bred to C57BL/6, and the FRT-neo cassette was removed by crossing with the *Flp* deleter line B6;SJL-Tg(ACTFLPe)9205Dym/J (Jackson Laboratories). PCR was used to verify loss of the cassette. These mice were referred to as *Trpm6^fl^*. To produce *Trpm*6*^CKO^* mice, we used the *Atoh1-Cre* mouse line (Matei et al., [@B37]), which recombines floxed genes in hair cells with \>99% efficiency (Avenarius et al., [@B4]). Floxed mice were genotyped using PCR, with GCTCCTCAGGGTTCCTCCAGTCTGT as the forward primer and GCAAGGACAAGAGGG-CGTCAGAGC as the reverse primer. The amplified samples were analyzed by electrophoresis; a wild-type allele produces a band of 670 bp, while the floxed-allele band is 833 bp.

We generated a mouse allele with the putative ion-conductance pore of *Trpm7* flanked by *loxP* sites. The 5′ arm (4948 bp) was PCR-amplified using a forward primer that introduced an *ApaI* site (GCGGGGCCCTGGGTGATTGACATTTCATTCCAAGT) and a reverse primer that introduced a *SalI* site (GCGGTCGACTGTCAACTAGCAATGGAAATGCAGACTT). This fragment was introduced into the pBS-FRT-Neo-FRT plasmid. The 3′ arm (2987 bp) was PCR-amplified using the forward primer GCGCTCGAGGTGTATATAAGAATTGTCTCAGGATAGT and reverse primer GCGCCGCGGCC-TCTTATCCTGTTTCTCTACATGTGT. A separate middle piece was prepared as a *SalI*/*NotI* fragment flanked by loxP sites; it was PCR-amplified using the forward primer GCGGTCGACGGTTTT-GCCTTATATTTGCAAGGCATA and reverse primer GCGGCGGCCGCCCATTACCATCATTCCTT-GAAGTGGCTTT. The middle piece was cloned into the 5′ arm vector at *SalI* and *NotI* sites; the 3′ arm was then cloned into this latter piece (5′ and middle). Founders were bred to C57BL/6, and the FRT-neo cassette was removed as above (producing *Trpm7^fl^* mice). *Trpm7^CKO^* mice were generated with *Atoh1-Cre* as above. Floxed mice were genotyped using PCR, with CCATACTGGATGATTTTTGGTG-AAGTTTATGCA as the forward primer and CACAAACAAGGAAGGGAAGAGTTTTAATATCCA as the reverse primer. The amplified samples were analyzed by electrophoresis; a wild-type allele produces a band of 514 bp, while the floxed-allele band is 633 bp.

Heterologous Expression in HEK Cells and Immunoprecipitation {#s2-3}
------------------------------------------------------------

For co-immunoprecipitation assays, we used HEK293T cells grown in six-well tissue culture plates. Cells were transfected with Effectene transfection reagent (Qiagen, \#301425) by preparing the DNA complex according to the manufacturer's suggested protocol in PCR tubes, then adding the DNA complex to the cells. Cells were harvested at 48 h, centrifuged briefly (16,000 *g* for 5 s), and the supernatant removed. To the pellet, 300 μl of cold lysis buffer containing PBS, 1% Triton X-100, 0.5% NP-40, and protease inhibitor cocktail (Sigma, \#P8340) was added, and the cells were then sonicated on ice using a tip sonicator (Ultracell Sonicator, Sonics) set at 25% power. The lysate was then centrifuged at 16,000 *g* for 20 min at 4°C, and the supernatant was separated from the pellet. A total of 10 μl of HA agarose (Sigma, \#A2095, 20 μl slurry) was added and the mixture was rotated overnight at 4°C. The immunoprecipitate mixture was centrifuged at 16,000 *g* for 1 s, then washed 2× with 300 μl lysis buffer and 1X with PBS. After the washes, 32 μl of 2× SDS sample buffer (Invitrogen) was added to the agarose beads, and the mixture was incubated for 10 min at 70°C. The agarose beads were removed using a spin filter (Costar \#8163), and 5 μl of 10× reducing agent (Invitrogen, \#NP0007) was added to the protein solution. The mixture was again incubated at 70°C for 10 min. The protein samples were separated on a 3%--8% Tris-acetate gel (Invitrogen, \#EA03755BOX) for 30--40 min. Proteins in the gel were then transferred to PVDF membrane (Millipore, \#IPVH00010) using a semi-dry setup (Bio-Rad, Transblot SD). Towbin buffer (25 mM Tris, 192 mM glycine, pH 8.3) with 10% MeOH and without SDS were used as transfer buffer. After transferring for 40--50 min, the blot was washed 1× in PBS and blocked in blocking buffer (PBS containing 10% FBS, 0.1% Tween) for 30 min, during which primary antibody were diluted in blocking buffer (1:1000) and incubated at room temperature for 10--20 min. The blot was incubated with primary antibody for 2 h at room temperature. After washing the blot, HRP-coupled secondary antibody, diluted 1:100 in blocking buffer, was incubated with the blot for 30 min. After washing, SuperSignal West Pico Chemiluminescent Substrate (Pierce, \#34077) was used for detection.

Anti-HA agarose or anti-V5 agarose (Sigma, \#A7345) were used to pull down HA-tagged TRP channels. For the PCDH15 pull down, we used 10 μg of PB811, a rabbit antibody against PCDH15 (Kazmierczak et al., [@B31]) or 10 μg of anti-HRP antibody (Jackson Immunoresearch), precipitating with 10 μl of Ultralink immobilized protein A (Pierce, \#53139). For protein immunoblotting, PCDH15 was detected with PB811 and TRP channels were detected with monoclonal anti-HA antibody (Applied Biological Materials, \#G036).

Mouse Hair-Cell Mechanotransduction: *Trpv6* Experiments {#s2-4}
--------------------------------------------------------

For these experiments, electrophysiological recordings from outer hair cells (OHCs) were carried out as previously described (Peng et al., [@B45]). For tissue preparation, organ of Corti explants from the mid-apex region were dissected from mice of either sex at ages P6--P9. The tissue was placed into the recording chamber and held in place with single strands of dental floss. Apical perfusion with external solution was used to protect the hair bundles from internal solution. The perfusion was carried out at a rate of \~0.1 ml/min using pipettes with tip size of \~50 μm. The external solution contained (in mM) 140 NaCl, 2 KCl, 2 CaCl~2~, 2 MgCl~2~, 10 (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; HEPES), 6 glucose, 2 sodium pyruvate, and 2 creatine phosphate, and was balanced to a pH of 7.4 and osmolality of 300--310 osmol/l.

Borosilicate patch pipettes (2.5--3.5 MΩ) were used to establish whole-cell recordings. The internal solution contained (in mM) 125 CsCl, 10 HEPES, 1 1,2-bis(o-aminophenoxy)ethane-N,N,N′, N′-tetraacetic acid (BAPTA), 5 ATP, 5 creatine phosphate, and 3.5 MgCl~2~; the pH was adjusted to 7.0 and osmolality 290--295 osmol/l. An Axopatch 200b amplifier was used to control electrode voltage and monitor current; the amplifier was controlled via JClamp software coupled to an IOtech interface. Cells were clamped at −80 mV. Recordings were included for data analysis if MET current amplitudes were stable prior to drug application and if the leak currents were less than 100 pA. For 70 cells recorded, the series resistance was 14.6 ± 7 MΩ (and was uncompensated); capacitance was 5.8 ± 0.8 pF. Data were included for analysis only if the series resistance changed less than 10% during recording. Only one cell was recorded per mouse and recordings were done blindly to animal genotype.

Hair bundles were stimulated in either of two ways (Peng et al., [@B45]). A glass probe affixed to a piezoelectric stack actuator (Thorlabs AE0505D08F or APC International PSt 150/7x7/7) controlled by JClamp software was placed in the central region of the hair bundle. The tip was shaped to that of the angled outer hair cell bundle. Driving voltage was filtered at 3 kHz to limit piezo resonance. The displacement was calibrated using an eyepiece reticule. Hair bundles were also stimulated as described (Peng et al., [@B45]) with fluid motion driven by a Picospritzer III.

Inhibitors, including \[2-(trimethylammonium)ethyl\] MTS bromide (MTSET; Toronto Research Chemicals \#T795900) or sodium (2-sulfonatoethyl) MTS (MTSES; Toronto Research Chemicals \#S672000), were aliquoted into single-use samples and kept frozen until a recording was obtained. The inhibitor was put into solution and applied to cells within 3 min of dissolving to avoid any breakdown of the compound; the inhibitor was hand pipetted into the recording chamber with enough exchanges so that the chamber volume was replaced 3×. The inhibitor was typically applied 10--15 min after breakthrough and the post-inhibitor measurements reported here were within 10 min of drug application. Longer application led to slow declines in current for both WT and mutant hair cells.

Mouse Hair-Cell Mechanotransduction: Mg^2+^ Substitution Experiments {#s2-5}
--------------------------------------------------------------------

For these experiments, electrophysiological recordings from OHCs were carried out as previously described (Xiong et al., [@B68]). For tissue preparation, organ of Corti explants from the mid-apex region were dissected from mice of either sex at ages P6--P7. The external solution contained (in mM): 144 NaCl, 0.7 NaH~2~PO4, 5.8 KCl, 1.3 CaCl~2~, 0.9 MgCl~2~, 5.6 glucose and 10 H-HEPES, pH 7.4.

Borosilicate patch pipettes (3--5 MΩ) were used to establish whole-cell recordings. The internal solution contained (in mM; in mM) 140 KCl, 0 or 3 MgCl~2~, 0.1 EGTA, 2 Na-ATP, 0.3 Na-GTP and 10 H-HEPES, pH 7.2. Transducer currents were sampled at 100 KHz with a patch-clamp amplifier operated by Patchmaster 2.35 software (EPC10-USB, HEKA). OHCs were clamped at −70 mV. An HEKA EPC10--2 USB amplifier with integrated interface and PatchMaster software was used to control electrode voltage and monitor current. Series resistance of 5--10 MΩ was automatically compensated by the PatchMaster software.

Hair bundles were deflected with a glass pipette mounted on a piezoelectric stack actuator (P-885, Physik Instruments). The tip of the pipette was fire-polished to 4--6 μm in diameter to fit the shape of OHC bundles. The actuator was driven with voltage steps that were low-pass filtered at 10 KHz with an eight-pole Bessel filter (900CTF, Frequency Devices). The displacement was calibrated with a high-magnification objective and high-resolution camera as described (Grillet et al., [@B24]).

Other Methods {#s2-6}
-------------

Yeast two-hybrid assays were conducted as described (Zhao et al., [@B71]). RT-PCR was carried out on whole vestibular system using previously described methods (Schwander et al., [@B53]) Gene-gun transfection and visualization of fluorescence protein-tagged constructs was carried using an optimized procedure (Zhao et al., [@B72]). For biolistic transfection, mouse cochleae were dissected at P6, subjected to gene-gun transfection, and then cultured for 1 day. Surface biotinylation was carried out with NHS-LC-Sulfo-biotin (Elia, [@B16]). Shotgun mass spectrometry on immunoprecipitates was carried out using a Thermo Velos ion-trap mass spectrometer; peptides and proteins were identified using the PAW pipeline and SEQUEST searches (Wilmarth et al., [@B64]; Krey et al., [@B33]). Auditory brainstem response (ABR) measurements were carried out as described (Schwander et al., [@B52]; Ebrahim et al., [@B15]). The Student's *t*-test was used for all pairwise comparisons (two-sided, two-sample equal variance). Data distribution was assumed to be normal but this was not formally tested.

Results {#s3}
=======

Evidence for Role of TRPV6 in Transduction {#s3-1}
------------------------------------------

While localization of PCDH15 to stereocilia tips does not depend on USH1C (Lefevre et al., [@B34]), PCDH15 and USH1C can bind directly under some conditions (Adato et al., [@B1]; Reiners et al., [@B49]), suggesting that USH1C might couple the transduction channel to PCDH15. Sequences of 33 TRP channel genes were scanned for PDZ binding interfaces (PBIs); seven that had candidate PBIs were tested in a yeast two-hybrid assay with USH1C as the bait (Figure [1A](#F1){ref-type="fig"}). Of these, only TRPV6 interacted with USH1C (Figure [1B](#F1){ref-type="fig"}). We carried out RT-PCR for *Trpv6* transcripts and found significant expression in vestibular tissues (Figure [1C](#F1){ref-type="fig"}). We noted that Trpv6 was also detected in the cochlea (Asai et al., [@B3]). Although immunocytochemistry experiments did not reliably detect TRPV6, the low levels of ion channels like TRP channels make detection very difficult (Gilliam and Wensel, [@B21]). These data raised the possibility that TRPV6 interacts with USH1C in hair cells, thus making TRPV6 a plausible transduction-channel candidate.

![Characterization of TRPV6. **(A)** Seven transient receptor channel (TRP) channels (of 33) with candidate PDZ-binding interface motifs. Yeast two-hybrid (Y2H) results examining interactions with USH1C (harmonin) are indicated.**(B)** The 33 terminal amino acids of the TRPV6 PBI interact with USH1C, but deletion of the C-terminal seven amino acids abolishes binding (top row). The interaction of TRPV6 is through PDZ1 of USH1C (bottom row). **(C)** RT-PCR (with reverse transcription primed either with oligo dT or random hexamers) showing that mRNA for TRPV6 is present in vestibular RNA.](fncel-12-00041-g0001){#F1}

MTS Reagents Do Not Affect Transduction in M527C-*Trpv6* Hair Cells {#s3-2}
-------------------------------------------------------------------

Individual knockouts of *Trpv6* or its close paralog *Trpv5* had no reported effects on auditory or vestibular function (Hoenderop et al., [@B26]; Bianco et al., [@B9]). These two genes are closely linked on human chromosome 7 or mouse chromosome 6 (Hoenderop and Bindels, [@B25]), so double knockouts cannot easily be created by breeding. To determine whether TRPV6 participates in hair-cell transduction, we developed a method whereby inhibition of a single channel subunit should lead to a dominant-negative effect on the tetrameric channel (Voets et al., [@B58]). We used cysteine-substitution mutagenesis to create a *Trpv6* allele that was sensitive to MTS reagents. Residue-scanning experiments with cysteine substitution and MTS inhibition demonstrated that the M527C mutation rendered TRPV6 sensitive to sulfhydryl reagents (Voets et al., [@B58]). We used standard gene-targeting methods to introduce mutations in the mouse genome that produced expression of the M527C-TRPV6 protein (Figure [2](#F2){ref-type="fig"}).

![Targeted mutations in mouse *Trpv6*, *Trpm6* and *Trpm7* genes. **(A)** Top, *Trpv6* gene structure. Horizontal gray line indicates scaled length of gene with coding exons, which are shown as vertical black rectangles. Middle, magnification of targeted exon. The *loxP* site remaining after excision of the *neo* cassette is shown in blue. Bottom, nucleotides and protein translation for region targeted. The M527C mutation is indicated.**(B)** Structure of the KcsA ion channel (image from <https://commons.wikimedia.org/wiki/File:1K4C.png>), along with the locations of the residue analogous to M527C-*Trpv6*. The pore and transmembrane domain 2 (TM2) are indicated as well. Two of the four subunits are shown. Color coding: protein, green; backbone carbonyl groups, oxygen in red and carbon in green; potassium ions (occupying S2 and S4), purple spheres; and oxygen atoms of water molecules (S1 and S3), red spheres.**(C)** Structure of *Trpm*6^*fl*^ allele; exon 7 is flanked by *loxP* recombination sites; a residual *FRT* site remaining after excision of the *Flp* cassette is indicated.**(D)** Structure of *Trpm*7^*fl*^ allele; exon 21 is flanked by *loxP* sites.](fncel-12-00041-g0002){#F2}

M527C-*Trpv6* mice were viable and exhibited no apparent behavioral abnormalities as heterozygotes or homozygotes. Transduction currents of heterozygous M527C-*Trpv6* OHCs under control conditions appeared normal in their amplitudes, kinetics, and adaptation (Figure [3](#F3){ref-type="fig"}). For example, maximum transduction currents were 527 ± 46 pA (mean ± SEM; *n* = 21) in WT hair cells and 514 ± 26 pA (*n* = 31) in M527C-*Trpv6* hair cells (*p* = 0.8 by Student's *t*-test). In wild-type mice, MTS reagents like MTSET and MTSES applied in the external solution had no effect on mechanotransduction in the absence of the sensitizing *Trpv* allele (Figure [3](#F3){ref-type="fig"}). This result shows that the cysteine-substitution approach should be suitable for probing the transduction channel; if MTS reagents had inhibited transduction currents of wild-type mice, we would not have be able to determine whether this or any other mutation had any impact.

![Methanethiosulfonate (MTS) reagents do not inhibit hair-cell transduction in M527C-*Trpv6* hair cells.**(A,B)** Hair-cell transduction currents from wild-type **(A)** and heterozygous M527C-*Trpv6* **(B)** mice before and after treatment with 1 mM MTSET, applied in the extracellular solution. Transduction currents were recorded with a holding potential of −80 mV.**(C,D)** Summarized data; each line connects a cell's control maximum current (before application of inhibitor) and its maximum current after application of 1 mM MTS reagents (MTSET or MTSES).](fncel-12-00041-g0003){#F3}

Unfortunately, extracellular treatment with 1 mM MTSET or MTSES, which inhibit TRPV6 activity by \>95% in tissue culture cells (Voets et al., [@B58]), also had no significant effects on mechanotransduction in heterozygous or homozygous M527C-*Trpv6* hair cells (Figure [3](#F3){ref-type="fig"}) when MTS reagents were applied in the external solution. There were no consistent changes in the maximal transduction current under these conditions for either wild-type or M527C-*Trpv6* heterozygotes over the course of the recording (Figures [3C,D](#F3){ref-type="fig"}). For WT hair cells, the maximum transduction current went from 527 ± 46 pA before application of MTS reagents to 474 ± 46 pA after (not significant; *p* = 0.4 by Student's *t*-test). For M527C-*Trpv6*, hair cells, the maximum transduction current went from 514 ± 26 pA before application of MTS reagents to 509 ± 33 pA after (*p* = 0.9). We conclude that TRPV6 does not participate in hair cell transduction.

TRPM6 and TRPM7 Co-immunoprecipitate with PCDH15 in Tissue-culture Cells {#s3-3}
------------------------------------------------------------------------

Based on its participation in mechanotransduction in other cell types, TRPM7 (and its close paralog TRPM6) is another plausible transduction channel candidate. We used heterologous expression of mouse proteins in HEK cells to investigate whether the TRPM channels can interact with PCDH15 (Figure [4](#F4){ref-type="fig"}). We cloned full-length *Trpm6* and *Trpm7* from cDNA prepared from mouse inner ear, tagged them with the HA epitope tag, and co-expressed them with native, full-length PCDH15 in HEK293 cells. After solubilizing proteins and immunoprecipitating, when HA-tagged TRPMs were expressed, we could immunoprecipitate PCDH15 with anti-HA beads but not with negative-control anti-V5 beads (Figure [4A](#F4){ref-type="fig"}; Supplementary Figure S1). Likewise, immunoprecipitation with the anti-PCDH15 antibody PB811 selectively co-precipitated TRPM6 and TRPM7 (Figure [4B](#F4){ref-type="fig"}; Supplementary Figure S2). Co-expression of TRPM6 and TRPM7 consistently led to substantially more PCDH15 immunoprecipitated than with either alone (Figure [4A](#F4){ref-type="fig"}).

![Interaction of PCDH15 with TRPM6 and TRPM7. **(A)** Lysates were immunoprecipitated with anti-HA agarose, and probed with anti-HA (top panels) or anti-PCDH15 antibody (bottom panels). PCDH15 was only immunoprecipitated by anti-HA if TRPM6 or RPM7 were present. No PCDH15 was precipitated by the control antibody (V5).**(B)** Lysates were immunoprecipitated with protein A/G agarose and either PB811 antibody (for PCDH15) or HRP antibody (control), then probed for TRP channels with anti-HA antibody. TRPM6 and TRPM7 were only precipitated with co-expressed with PCDH15 and precipitated with an anti-PCDH15 antibody. **(C)** Lysates were immunoprecipitated with anti-HA agarose, and probed with anti-PCDH15 antibody (left panels) or CDH2 antibody (right). Two C-terminal deletion proteins of PCDH15, Δ1 and Δ2, did not immunoprecipitate with TRPM6/7. Chimeras that have N-terminal extracellular domains of PCDH15 (15--2--15 and 15--2--2) immunoprecipitated with TRPM6/7 more strongly than PCDH15. The chimera that does not contain extracellular domains of PCDH15 (2--15--2) did not immunoprecipitate with TRPM6/7. **(D)** Lysates were immunoprecipitated with anti-HA agarose and probed with an anti-PCDH15 antibody (PB811). The last two lanes are two controls: anti-V5 agarose as a control for non-specific binding of the agarose with PCDH15, and TRPC6 as a TRP channel outside the TRPM family. Both controls have much lower levels of PCDH15 immunoprecipitated. **(E)** Summary of PCDH15 constructs (N- to C-terminal) used in panel **(C)**. Chimeras with CDH2 used the CD3 splice form of PCDH15. **(F)** Mass spectrometry spectral counts for TRPM6, TRPM7, and PCDH15 in large-scale immunoprecipitation experiments using ant-HA agarose. No PCDH15 was immunoprecipitated when it was expressed alone, but large amounts were co-precipitated with TRPM6 and TRPM7.](fncel-12-00041-g0004){#F4}

To demonstrate the selectivity of the interaction, we showed that a different cadherin, CDH2 (N-cadherin), was not immunoprecipitated with HA-tagged TRPM6 or TRPM7 (Figure [4C](#F4){ref-type="fig"}; Supplementary Figure S3), nor was PCDH15 immunoprecipitated with HA-TRPC6, a different TRP channel (Figure [4D](#F4){ref-type="fig"}; Supplementary Figure S4). Co-expression was important; if HA-tagged TRPMs were expressed in separate samples from those of PCDH15 and the cell extracts were mixed, no PCDH15 was immunoprecipitated with HA-tagged TRPMs (data not shown). Deletion of the C-terminus of PCDH15 eliminated the interaction, but chimeras of PCDH15 and CDH2 that contained only the N-terminal extracellular domain of PCDH15 robustly co-precipitated TRPM6 and TRPM7 (Figure [4C](#F4){ref-type="fig"}).

To determine whether any endogenous HEK proteins mediated the interaction between the TRPMs and PCDH15, we carried out a larger scale immunoprecipitation and subjected the final eluates to tandem mass spectrometry. When expressed by itself and immunoprecipitated by HA-agarose, no PCDH15 was detected in eluates. By contrast, when TRPM6 and TRPM7 were co-expressed with PCDH15, all three proteins were detected at high levels in the immune pellet eluates (Figure [4F](#F4){ref-type="fig"}). Besides human heat shock protein cognate 71, no additional proteins co-immunoprecipitated at apparent stoichiometric levels, suggesting that the TRPM-PCDH15 interaction is direct.

tdTomato-TRPM7 Localizes to Hair Cell Lateral Membranes at the Cell Apex {#s3-4}
------------------------------------------------------------------------

Localization of TRP channels by immunocytochemistry is generally unreliable (Gilliam and Wensel, [@B21]). Instead, we generated a *tdTomato-Trpm7* plasmid and transfected it into hair-cell progenitors at P6 using gene-gun transfection. Transfection efficiency was poor, presumably because of the large size of the expression construct. We were able to identify several transfected cells using co-expressed ZsGreen (Figure [5A](#F5){ref-type="fig"}), and found tdTomato signal that was largely localized to the lateral membranes of hair cells, close to the adherens junctions (Figure [5B](#F5){ref-type="fig"}). While not detected in stereocilia, the location of tdTomato-TRPM7 close to the hair cell's apical domain raised the possibility that small amounts of TRPM7 could be transported to stereocilia membranes.

![Localization of TRPM7 in the inner ear. **(A)** Single x-y slice through apical region of outer hair cells. One transfected cell, identified by ZsGreen signal, shows tdTomato signal at the lateral membrane. Box indicates region used for x-z reslice in **(B)**. P6+1, cochlea dissected at P6 and maintained in culture for 1 day. **(B)** Reslice of stack shows lateral view of transfected hair cell (in row 2; OHC2) and two other untransfected cells. tdTomato-TRPM7 signal was located near apex of cell. Red signal outside of OHC2 is presumably background fluorescence. Panel full widths in **(A,B)** are 15 μm.](fncel-12-00041-g0005){#F5}

Identification of a Novel *Trpm7* Splice Form in Inner Ear {#s3-5}
----------------------------------------------------------

When cloning full-length *Trpm6* and *Trpm7* from cDNA prepared from mouse inner ear, we also identified novel splice forms that skipped exon 20 of each gene, which in both genes encodes transmembrane helix 2 (TM2). Using RT-PCR analysis, we found that while the canonical *Trpm7* splice form was expressed in all mouse tissues, *Dex27* (the *Trpm7* splice form lacking exon 20) was restricted to inner ear, heart, and liver. *Dex26* was expressed in a variety of tissues, including the inner ear (Figure [6A](#F6){ref-type="fig"}).

![Novel splice forms of *Trpm6* and *Trpm7* interact with PCDH15. **(A)** Tissue expression profiles of mouse *Trpm6*, *Dex27* and *Dex26*. Primer sets for *Dex27* and *Dex26* were designed such that they bind to the junctions of *Trpm7* and *Trpm6* exons 19 and 21; signal was only seen if exon 20 was absent. Both *Dex27* and *Dex26* were highly expressed in the ear (first lane on the left). **(B)** Both TRPM6/7 and DEX26/7 proteins traveled to the cell surface. HEK293T cells were transfected with TRPM6/7 or DEX26/7; before harvest, the cells were surface biotinylated. Cell lysates were then immunoprecipitated with neutravidin-agarose, then probed with anti-HA antibody. **(C)** DEX26 and DEX27 interacted with PCDH15 in a similar fashion with TRPM6 and TRPM7. **(D)** Predicted membrane topology for canonical TRPM7 sequence (left) and hypothetical inverted DEX27 sequence (right). The loss of TM2 when exon 20 is spliced out could force inversion of TM3--TM6; a cryptic transmembrane domain (S7 here) is predicted by some topology algorithms to be used, maintaining the N- and C-termini intracellular.](fncel-12-00041-g0006){#F6}

Interestingly, both DEX26 and DEX27 were readily expressed in HEK293 cells and were present on the cell surface, as assessed by a surface biotinylation assay (Figure [6B](#F6){ref-type="fig"}; Supplementary Figure S5). DEX26 and DEX27 both co-immunoprecipitated PCDH15 as efficiently as the canonical splice forms (Figure [6C](#F6){ref-type="fig"}; Supplementary Figure S6), and could be co-immunoprecipitated with the canonical forms.

Mechanotransduction Does Not Require *Trpm6* or *Trpm7* {#s3-6}
-------------------------------------------------------

Our protein interaction results raised the possibility that TRPM6 or TRPM7 mediates mechanotransduction by hair cells. A characteristic of TRPM6 and TRPM7 conductances is that they are blocked by intracellular Mg^2+^ (Nadler et al., [@B38]; Voets et al., [@B59]). Hair-cell transduction was not affected by manipulations of Mg^2+^, however; currents appeared identical if recorded in the presence of 0 or 3 mM intracellular MgCl~2~ in the internal solution (Figure [7A](#F7){ref-type="fig"}). In recording from five cells for each condition, maximum transduction currents were reduced slightly but not significantly (*p* = 0.6; Student's *t*-test) comparing cells recorded with 3 mM Mg^2+^ (599 ± 32 pA; mean ± SEM) with those with 0 mM Mg^2+^ (637 ± 60 pA; Figure [7B](#F7){ref-type="fig"}). Parameter values for three-state Boltzmann fits to displacement-*P~open~* data were within experimental error for 0 and 3 mM Mg^2+^ (Figure [7C](#F7){ref-type="fig"}).

![No evidence for contribution of TRPM6 or TRPM7 conductances to hair-cell transduction or auditory function.**(A--C)** No effect of internal Mg^2+^. **(A)** Representative transduction currents from hair cells that were dialyzed with internal solution containing 0 or 3 mM MgCl~2~. **(B)** No difference in transduction current amplitudes were observed. Mean ± SEM are plotted and fit with a three-state Boltzmann relation; *n* = 5 for each. **(C)** Replotted as displacement-*P*~open~ relationship. Boltzmann fits are nearly identical. **(D)** Examples of auditory brainstem response (ABR) waveforms at 32 kHz for WT (*Trpm6^fl/fl^*; *Trpm7*^fl/fl^; *Atoh1-CRE*-negative) and *Trpm6^CKO^*; *Trpm7^CKO^* DKO mice. The bold red trace for each indicates the threshold (30 and 35 dB SPL, respectively). **(E)** Summarized ABR measurements for *Trpm6^CKO^*, *Trpm7^CKO^*, and *Trpm6^CKO^*; *Trpm7^CKO^* DKO mice. Mean ± SEM are plotted. *Trpm6^CKO^* : WT, *n* = 11; *Trpm6^CKO^*, *n* = 17. \*\**p* \< 0.01. *Trpm7^CKO^*: WT, *n* = 10; *Trpm7^CKO^*, *n* = 14. *Trpm6^CKO^*; *Trpm7^CKO^* DKO: WT, *n* = 11; *Trpm6^CKO^*; *Trpm7^CKO^* DKO, *n* = 8.](fncel-12-00041-g0007){#F7}

To determine definitively whether TRPM6 or TRPM7 participate in hair-cell mechanotransduction, we produced *Trpm6^fl^* and *Trpm7^fl^* mice (Figure [2](#F2){ref-type="fig"}) and expressed CRE recombinase in hair cells to delete essential exons for each gene. Global-null *Trpm*6^Δ/Δ^ mice rarely survive past birth due to Mg^2+^ insufficiency (Walder et al., [@B61]; Woudenberg-Vrenken et al., [@B65]), and global-null *Trpm*7^Δ/Δ^ mice have an embryonic lethality phenotype (Jin et al., [@B29]). We therefore used the *Atoh1-Cre* transgenic line to restrict *Trpm6* and *Trpm7* deletion to hair cells and a few other cell types (Matei et al., [@B37]; Pan et al., [@B44]). Mice with both alleles recombined by CRE are referred to here as *Trpm6^CKO^* or *Trpm7^CKO^*.

*Trpm6^CKO^*, *Trpm7^CKO^* and *Trpm6^CKO^*;*Trpm7^CKO^* (double knockout, or DKO) mice were behaviorally normal, with no indication of gross auditory or vestibular disruption. We assessed auditory function using ABR measurements (Figures [7D,E](#F7){ref-type="fig"}). While ABR thresholds at 32 kHz were slightly but significantly elevated for *Trpm6^CKO^* mice, thresholds were not statistically significant different for *Trpm7^CKO^* or *Trpm6^CKO^*;*Trpm7^CKO^* DKO mice as compared to controls at all frequencies (Figure [7E](#F7){ref-type="fig"}). These results suggest that neither TRPM6 nor TRPM7 is a major contributor the mechanotransduction.

Discussion {#s4}
==========

Our experimental results suggest that TRPV6, TRPM6 and TRPM7 are not involved in hair-cell transduction. While each of these TRP channels had plausible initial evidence supporting their involvement, direct experiments---allele-specific inhibition for TRPV6, and single and double knockouts for TRPM6 and TRPM7---gave no support for a role of any of them in forming the hair cell's transduction pore. While these results do not provide direct evidence for the participation of TMC1 and TMC2 in forming the pore, the paucity of viable alternative candidates lends indirect support for the two TMCs.

Inhibition of TRPV6 Does Not Interfere with Hair-Cell Mechanotransduction {#s4-1}
-------------------------------------------------------------------------

When applied in the external solution, MTS reagents did not inhibit transduction currents measured in hair cells of M527C-*Trpv6* mice. In cell culture, each of these residues can be robustly inhibited from the extracellular side of the membrane (Dodier et al., [@B14]; Voets et al., [@B58]), so the lack of MTS inhibition of transduction in mutant hair cells suggests that TRPV6 does not contribute to the transduction channel.

Like allele-selective inhibition of myosins (Gillespie et al., [@B20]; Holt et al., [@B27]), this strategy provides strong evidence for the role of a protein in a biological function; three control conditions (wild-type, wild-type plus inhibitor, mutant) are matched with one experimental condition (mutant plus inhibitor), strengthening the interpretation of an inhibitory effect. To definitively establish the viability of the cysteine substitution/MTS inhibition approach with this channel, future experiments could determine whether Ca^2+^ transport in intestine, mediated by TRPV6 (Nijenhuis et al., [@B39]), is inhibited when the M527C allele is present and MTS reagents are applied.

Elimination of *Trpm6* or *Trpm7* Does Not Interfere with Auditory Function {#s4-2}
---------------------------------------------------------------------------

Single and double knockouts of *Trpm6* and *Trpm7* had no effect on mouse hearing. While demonstrating conclusively that *Trpm6* and *Trpm7* transcripts are eliminated in hair cells is difficult because of the low level of expression (making *in situ* mRNA localization challenging) and expression in other cochlear cell types (preventing analysis of whole cochlea to assess transcript loss), recombination by Atoh1-CRE occurs robustly during hair cell development (Matei et al., [@B37]; Pan et al., [@B44]). We assessed ABRs at 4--8 weeks of age, and it is very unlikely that *Trpm7* mRNA or TRPM7 protein would be stable for so long after the genes were recombined. Nevertheless, even though there are limitations to our experiments, they nonetheless strongly suggest that TRPM6 and TRPM7 are not part of the transduction channel.

TRPM6 and TRPM7 Bind to PCDH15 {#s4-3}
------------------------------

Our results suggest that under some circumstances, TRPM6 and TRPM7 can bind to PCDH15, a component of the tip link. Because TRPM6 and TRPM7 are not essential for hearing, these results suggest that TRPM6 and TRPM7 might interact with PCDH15 elsewhere besides the transduction complex. One possibility is that the TRPMs are present in kinocilia, and interact with the PCDH15 molecules that contribute to the kinocilial links (Goodyear et al., [@B23]). If so, the TRPMs are unlikely to play an essential role in kinocilia-link function, as loss of kinocilial links leads to deafness (Webb et al., [@B62]) but loss of the TRPMs does not affect hearing. Alternatively, RNA-seq experiments show that PCDH15 is expressed in inner-ear cell types besides hair cells (Burns et al., [@B10]), and so these channels could form complexes with PCDH15 there.

An alternative view is that PCDH15 or the TRPMs bind membrane proteins promiscuously, which may call into question interactions described based on similar immunoprecipitation experiments (Ramakrishnan et al., [@B48], [@B47]; Maeda et al., [@B36]; Beurg et al., [@B8]; Cunningham et al., [@B13]; Erickson et al., [@B17]). While our experiments were well controlled, including the use of alternative cadherins and TRP channels, reliance simply on cell-culture immunoprecipitation experiments is fraught. Such evidence should always be backed up by alternative experiments that lack some of the ambiguity of *in vitro* experiments.

Novel *Trpm6* and *Trpm7* Splice Forms {#s4-4}
--------------------------------------

We identified splice forms of *Trpm6* and *Trpm7* that each lack exon 20, which encodes most of transmembrane domain 2 in each channel. DEX26 and DEX27 were targeted to the surface of HEK293 cells, and, like the canonical versions of TRPM6 and TRPM7, interacted with PCDH15 via its extracellular domain. Membrane topology programs suggested the possibility that DEX26 and DEX27 have partially inverted transmembrane domain regions, so that the pore of the channel is a re-entrant loop coming from the inside rather than the outside (Figure [6D](#F6){ref-type="fig"}). This topology is speculative at this moment, however, as we have no experimental evidence that the pore is flipped. If this topology is correct, however, it limits the regions of the TRPM proteins that PCDH15 can interact with from the N-terminus through TM2 and from the cryptic TM7 to the C-terminus. Regardless of whether the channel's pores are inverted, the loss of TM2 will force an unusual topology on this channel, however, and it will be interesting to follow up the role of these splice forms in the organism.

Implications for Identification of the Hair Cell's Transduction Channel {#s4-5}
-----------------------------------------------------------------------

Our results rule out several transduction channel candidates, adding to the list of channels disproven that includes P2RX2, SCNN1A, TRPN1, TRPA1, TRPV4, TRPML3, TRPC3, TRPC5, TRPC6, TRPM1, TRPM2, TRPM3, PKD1, PKD1L3, PKD2, PKD2L1 and PKD2L2 (Rüsch and Hummler, [@B50]; Vollrath et al., [@B60]; Steigelman et al., [@B56]; Fettiplace and Kim, [@B18]; Wu et al., [@B66]). Because of their essential role in mechanotransduction and their size, the TMCs remain the best candidate for the transduction channel's pore. Nonetheless, the TMCs still have not been conclusively demonstrated to form ion channels, necessary for showing that a given molecule forms the transduction pore.

The cysteine-substitution/MTS inhibition approach could serve as a useful tool for testing additional transduction channel candidates, although the accurate knowledge of the location of the modified residues from cysteine-scanning mutagenesis (Dodier et al., [@B14]; Voets et al., [@B58]) is essential, as is confirmation of the location of the modified residues in the protein structure (Saotome et al., [@B51]). Moreover, as modification of cysteines could allosterically affect channel function, perhaps even mediated through protein-protein interactions, the cysteine/MTS approach does not definitively prove that the modified residue is in the tested channel's pore. Perhaps the most conclusive test for the transduction channel would be to change the ion selectivity of the pore based on knowledge of channel structure, and then show that hair-cell transduction ion selectivity changes in the predicted manner.
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